These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 12688177)
1. [The International Prognostic Scoring System for primary myelodysplastic syndrome]. Sisková M; Dohnalová A; Neuwirtová R; Pĕnicková J; Karban J; Cmunt E Sb Lek; 2002; 103(3):333-8. PubMed ID: 12688177 [TBL] [Abstract][Full Text] [Related]
2. Detection of risk groups in myelodysplastic syndromes. A multicenter study. Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460 [TBL] [Abstract][Full Text] [Related]
3. [Analysis of 4 prognostic scoring systems in 197 myelodysplastic syndrome patients]. Rubio-Félix D; Giraldo MP; Perella M; Gimeno J; Franco E; Giralt M Sangre (Barc); 1991 Dec; 36(6):463-9. PubMed ID: 1812580 [TBL] [Abstract][Full Text] [Related]
4. [Myelodysplastic syndrome--classification, prognosis and therapy]. Cermák J; Michalová K; Vítek A Cas Lek Cesk; 2002 Sep; 141 Suppl():33-7. PubMed ID: 12428420 [TBL] [Abstract][Full Text] [Related]
5. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis. Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299 [TBL] [Abstract][Full Text] [Related]
7. International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes. Kao JM; McMillan A; Greenberg PL Am J Hematol; 2008 Oct; 83(10):765-70. PubMed ID: 18645988 [TBL] [Abstract][Full Text] [Related]
8. A comparative review of classification systems in myelodysplastic syndromes (MDS). Bennett JM Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011 [TBL] [Abstract][Full Text] [Related]
9. Myelodysplastic syndromes: a community hospital-based study of prognostic factors and International Prognostic Scoring System. Mirza I; Garzón R; Burns J; Edwards L; Fernandez-Cymering C; Kloss R Conn Med; 2001 Aug; 65(8):455-63. PubMed ID: 11550445 [TBL] [Abstract][Full Text] [Related]
10. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935 [TBL] [Abstract][Full Text] [Related]
11. [An analysis of prognostic factors in 80 myelodysplastic syndrome]. Xu XQ; Wang JM; Lu SQ; Chen L; Yang JM; Zhang WP; Song XM; Xu YQ; Gong SL; Hou J; Ni X Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):723-7. PubMed ID: 19176004 [TBL] [Abstract][Full Text] [Related]
12. Evaluating the prognosis of patients with myelodysplastic syndromes. Aul C; Giagounidis A; Germing U; Ganser A Ann Hematol; 2002 Sep; 81(9):485-97. PubMed ID: 12373348 [TBL] [Abstract][Full Text] [Related]
13. [Karyotypic and IPSS grouping of primary myelodysplastic syndromes patients: a comparison between FAB- and WHO-classification]. Yu MH; Liu SH; Shao YQ; Hao YS; Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):482-5. PubMed ID: 15555265 [TBL] [Abstract][Full Text] [Related]
14. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes. Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505 [TBL] [Abstract][Full Text] [Related]
15. Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome. Lee JH; Lee JH; Shin YR; Lee JS; Kim WK; Chi HS; Park CJ; Seo EJ; Lee KH Leukemia; 2003 Feb; 17(2):305-13. PubMed ID: 12592327 [TBL] [Abstract][Full Text] [Related]
16. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients. Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393 [TBL] [Abstract][Full Text] [Related]
17. [Prediction of survival in myelodysplastic syndrome. Analysis of 2 scoring systems with prognostic value]. Sanz GF; Sanz MA; Vallespí T; Cañizo MC; García S; Torrabadella M; San Miguel JF; Irriguible D Sangre (Barc); 1989 Feb; 34(1):41-6. PubMed ID: 2711284 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. Malcovati L; Porta MG; Pascutto C; Invernizzi R; Boni M; Travaglino E; Passamonti F; Arcaini L; Maffioli M; Bernasconi P; Lazzarino M; Cazzola M J Clin Oncol; 2005 Oct; 23(30):7594-603. PubMed ID: 16186598 [TBL] [Abstract][Full Text] [Related]
19. Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS. Park MJ; Kim HJ; Kim SH; Kim DH; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW Eur J Haematol; 2008 Nov; 81(5):364-73. PubMed ID: 18637029 [TBL] [Abstract][Full Text] [Related]
20. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. Germing U; Strupp C; Kuendgen A; Isa S; Knipp S; Hildebrandt B; Giagounidis A; Aul C; Gattermann N; Haas R Haematologica; 2006 Dec; 91(12):1596-604. PubMed ID: 17145595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]